Strategic agreement with Modawina Medical Company strengthens SHINE’s presence in EMEA region and advances access to Ilumira, n.c.a. lutetium 177 SHINE Technologies, LLC, a nuclear...
AdvanCell, a clinical-stage radiopharmaceutical company specializing in targeted alpha therapies, today announced an expansion to the scope and breadth of its strategic collaboration with Eli...